[HTML][HTML] Genetics of chloroquine-resistant malaria: a haplotypic view
The development and rapid spread of chloroquine resistance (CQR) in Plasmodium
falciparum have triggered the identification of several genetic target (s) in the P. falciparum …
falciparum have triggered the identification of several genetic target (s) in the P. falciparum …
Situation of insecticide resistance in malaria vectors in the World Health Organization of Eastern Mediterranean region 1990–2020
Malaria is the most important mosquito-borne disease, which is transmitted by Anopheles
species. According to the recent report of World Health Organization, there were an …
species. According to the recent report of World Health Organization, there were an …
An insight to better understanding cross border malaria in Saudi Arabia
Background Border malaria is a major obstacle for the malaria elimination in Saudi Arabia.
Today, the southern border of Saudi Arabia is a region where malaria cases are resurging …
Today, the southern border of Saudi Arabia is a region where malaria cases are resurging …
Characterization of drug resistance and genetic diversity of Plasmodium falciparum parasites from Tripura, Northeast India
SJ Patgiri, K Sarma, N Sarmah, N Bhattacharyya… - Scientific Reports, 2019 - nature.com
Monitoring of anti-malarial drug resistance is vital in Northeast India as this region shares its
international border with Southeast Asia. Genetic diversity of Plasmodium parasites …
international border with Southeast Asia. Genetic diversity of Plasmodium parasites …
Assessment of Plasmodium falciparum anti-malarial drug resistance markers in pfcrt and pfmdr1 genes in isolates from Honduras and Nicaragua, 2018–2021
Abstract Background Central America and the island of Hispaniola have set out to eliminate
malaria by 2030. However, since 2014 a notable upturn in the number of cases has been …
malaria by 2030. However, since 2014 a notable upturn in the number of cases has been …
The return of chloroquine-sensitive Plasmodium falciparum parasites in Jazan region, southwestern Saudi Arabia over a decade after the adoption of artemisinin-based …
This study investigated the polymorphism in the P. falciparum chloroquine resistance
transporter (pfcrt) gene 11 years after chloroquine (CQ) cessation in Jazan region …
transporter (pfcrt) gene 11 years after chloroquine (CQ) cessation in Jazan region …
Pfcrt 76T and pfmdr1 86Y allele frequency in Plasmodium falciparum isolates and use of self-medication in a rural area of Gabon
DP Mawili-Mboumba, JM Ndong Ngomo… - Transactions of the …, 2014 - academic.oup.com
Background Studies showed that chloroquine resistance may revert to sensitivity after its
withdrawal mainly detected by a significant decrease of Plasmodium falciparum pfcrt 76T …
withdrawal mainly detected by a significant decrease of Plasmodium falciparum pfcrt 76T …
Selection of pfdhfr/pfdhps alleles and declining artesunate/sulphadoxine-pyrimethamine efficacy against Plasmodium falciparum eight years after deployment in …
NB Gadalla, TM Abdallah, S Atwal, CJ Sutherland… - Malaria journal, 2013 - Springer
Background Artesunate/sulphadoxine-pyrimethamine (AS/SP) has been the first-line
treatment for falciparum malaria in Sudan since 2004. The impact of this combination on anti …
treatment for falciparum malaria in Sudan since 2004. The impact of this combination on anti …
Microsatellite markers reveal low levels of population sub-structuring of Plasmodium falciparum in southwestern Nigeria
Background Genetic diversity studies provide evidence of Plasmodium falciparum
differentiation that could affect fitness and adaptation to drugs and target antigens for …
differentiation that could affect fitness and adaptation to drugs and target antigens for …
High efficacy of two artemisinin-based combinations: artesunate+ sulfadoxine-pyrimethamine and artemether-lumefantrine for falciparum malaria in Yemen
AA Adeel, NA Saeed, A Aljasari, AM Almohager… - Malaria journal, 2015 - Springer
Background Artesunate+ sulfadoxine-pyrimethamine (AS+ SP) has been the first-line
treatment and artemether-lumefantrine (AL) the second-line treatment for uncomplicated …
treatment and artemether-lumefantrine (AL) the second-line treatment for uncomplicated …